Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
Just nowMAX Power Announces Strategic $25 Million Investment by Eric Sprott to Accelerate Commercial Advancement of Canada’s First-Ever Subsurface Natural Hydrogen System
Just nowDLP Resources Announces Closing of Brokered Offering for Gross Proceeds of C$6 Million
Just nowData Storage Corporation Announces Expiration of Public Warrants (NASDAQ: DTSTW)
1m agoMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
1m agoParatus Energy: Invitation to Q1 2026 Earnings Call
Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

About

8.03USD+0.04 +0.50%
Closed • Updated at 13:14 GMT+00:00
Market Cap$1.76B
Volume4.66M
Beta1.07
RSI33.51
Gross Margin87.24%
Health TechnologyPharmaceuticals: Major

Ocular Therapeutix, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
Apr 29 2026
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
Apr 28 2026
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Apr 27 2026
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
Apr 22 2026
Ocular Therapeutix™ to Host Investor Day on June 17, 2026

Community Chat

Ask AI

6ix6ixAIEvents